HomeProductsBioactive CompoundsAnti-Infective AgentsHCVAcyclic retinoid
Chemical structure of CAS 81485-25-8

Acyclic retinoid

In Stock•Starting at $62 for 1 mg•Purity ≥ 99%
CAS No.81485-25-8
MDL No.MFCD01742209
MFC20H30O2
MW302.50
InChI KeyUUBHZHZSIKRVIV-KCXSXWJSSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg99%$62In Stock
2 mg99%$72In Stock
5 mg99%$109In Stock
10 mg99%$201In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.81485-25-8
Product NameAcyclic retinoid

Associated Conditions

liver cancer
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.

Cancer prevention research (Philadelphia, Pa.) • Vol. 4, Issue 1 • 2011
PMID: 21071580DOI: 10.1158/1940-6207.CAPR-10-0163

An antioxidant effect by acyclic retinoid suppresses liver tumor in mice.

Biochemical pharmacology • Vol. 73, Issue 9 • 2007
PMID: 17261273DOI: 10.1016/j.bcp.2006.12.030

Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cells.

Cancer science • Vol. 98, Issue 3 • 2007
PMID: 17270033PMC: PMC11158363DOI: 10.1111/j.1349-7006.2006.00384.x

NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-kappaB signal pathway.

Molecular cancer therapeutics • Vol. 5, Issue 3 • 2006
PMID: 16546985DOI: 10.1158/1535-7163.MCT-05-0434

Documentation

Similar Products